Detail akcie Iconovo Rg online

Business Summary: Iconovo AB is a Sweden-based company, which offers inhalation solutions for pharmaceutical companies. Solutions are based on the Company’s device platforms and include formulation, analytical testing and documentation. Iconovo Ab develops products, which are a part of device family and include: ICOres, reservoir devices, ICOone, disposable unit-dose devices, ICOcap, capsule-based devices and ICOpre, pre-metered devices. Moreover, the Company offers programs, which include development of generic inhalation products, where the products are registered based on therapeutic equivalence; development of inhalation products based on a generic application programming interface (API) and new chemical entity (NCE); as well as phase I-II clinical trials using ICOone.
Financial Summary: BRIEF: For the three months ended 31 March 2026, Iconovo AB revenues increased 45% to SEK675K. Net loss decreased 28% to SEK8.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Personnel Expenses decrease of 45% to SEK4.8M (expense), Depreciation/Amortization of Assets decrease of 22% to SEK2M (expense).